Early Intervention in COVID-19: Favipiravir Verses Standard Care

NCT04373733 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

502

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Infection

Interventions

DRUG: Favipiravir
OTHER: Standard of care management

Sponsor

Chelsea and Westminster NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]